Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRSP

CRISPR Therapeutics AG

May 26 • 03:07PM ET

50.72

+0.36 0.72 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: NTLA BEAM EDIT PRME VRTX

| Held by: ARKK IWM XBI ARKG VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.15%	Shs Outstand	96.39M	Perf Week	4.46%
Market Cap	4.89B	Forward P/E	-	EPS next Y	-3.73	Insider Trans	-3.21%	Shs Float	89.55M	Perf Month	3.98%
Enterprise Value	3.24B	PEG	-	EPS next Q	-1.19	Inst Own	72.72%	Short Float	25.11%	Perf Quarter	-10.65%
Income	-568.53M	P/S	1193.26	EPS this Y	25.26%	Inst Trans	1.52%	Short Ratio	11.77	Perf Half Y	2.91%
Sales	4.10M	P/B	2.69	EPS next Y	22.89%	ROA	-23.24%	Short Interest	22.48M	Perf YTD	-3.27%
Book/sh	18.83	P/C	2.00	EPS next 5Y	29.69%	ROE	-31.21%	52W High	78.48 -35.37%	Perf Year	37.62%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	35.38 43.37%	Perf 3Y	-21.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	3.85% 5.28%	Perf 5Y	-57.20%
Dividend TTM	-	EV/Sales	789.71	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	48.21	Recom	1.96
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	-1.42%	Beta	1.72	Target Price	78.45
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	-0.65%	Rel Volume	0.53	Prev Close	50.36
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-8.96%	Avg Volume	1.91M	Price	50.72
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	889,066	Change	0.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)